Zaloguj Zarejestruj się zadarmo

Albireo Pharma Inc organizacji Przychody Y / Y

Jaka jest wartość Przychody Y / Y organizacji Albireo Pharma Inc?

Wartość Przychody Y / Y organizacji Albireo Pharma Inc to 432.68%

Jaka jest definicja Przychody Y / Y?

Roczny wzrost przychodów z ostatnich 3 lat to wzrost przychodów z jednego roku do drugiego uśredniony w ciągu ostatnich 3 lat.

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Przychody Y / Y firm w Health Care sektor na NASDAQ w porównaniu do Albireo Pharma Inc

Czym się zajmuję organizacja Albireo Pharma Inc?

Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.

Firmy z przychody y / y podobne do Albireo Pharma Inc